Emergent BioSolutions
EBS
#6745
Rank
HK$5.00 B
Marketcap
HK$93.81
Share price
3.88%
Change (1 day)
27.79%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2025 (TTM): HK$1.28 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are HK$0.75 Billion. In 2024 the company made an earning of -HK$0.56 Billion, an increase over its 2023 earnings that were of -HK$5.01 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$1.28 B-329.79%
2024 -HK$0.56 Billion-88.82%
2023 -HK$5.01 Billion242.73%
2022 -HK$1.47 Billion-153.8%
2021 HK$2.71 B-20.43%
2020 HK$3.41 B278.02%
2019 HK$0.90 B27.11%
2018 HK$0.71 B-27.12%
2017 HK$0.97 B17.21%
2016 HK$0.83 B0.45%
2015 HK$0.82 B73.51%
2014 HK$0.47 B41.36%
2013 HK$0.33 B35.2%
2012 HK$0.24 B0.4%
2011 HK$0.24 B-56.46%
2010 HK$0.57 B76.73%
2009 HK$0.32 B32.94%
2008 HK$0.24 B-5.62%
2007 HK$0.25 B
2005 HK$0.37 B269.89%
2004 HK$0.10 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Merck
MRK
HK$179.74 B 13,868.54%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
HK$0.70 B-45.38%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$72.57 B 5,539.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-HK$2 Billion-255.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$92.26 B 7,069.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$13.79 B 971.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
-HK$96.29 Million-107.48%๐Ÿ‡บ๐Ÿ‡ธ USA